期刊文献+

弓形虫复合粘膜疫苗滴鼻免疫小鼠诱导的Peyer's patches持续性细胞免疫应答 被引量:2

Persistent cellular immune responses of Peyer's patches in mice induced by intranasal immunization with Toxoplasma gondii mucosal vaccine in mice
下载PDF
导出
摘要 目的以可溶性速殖子抗原(soluble tachyzoite antigen,STAg)和霍乱毒素(choleratoxin,CT)佐剂制备的弓形虫复合粘膜疫苗滴鼻免疫小鼠,观察肠粘膜诱导部位Peyer’s patches(PP)的细胞免疫应答及持续时间,探讨其免疫机制。方法BALB/c小鼠96只,随机分为实验组和对照组,实验组以STAg(20μg/只)为抗原,CT(1/μg/只)为佐剂滴鼻免疫,对照组PBS滴鼻。滴鼻2次(间隔2周)后,每组6只小鼠分别于第1、2、3、4、6、8、10、12周处死。计数PP个数,制备PP淋巴细胞悬液,计数并涂片;免疫细胞化学法检测CD4^+、CD8^+T细胞亚群。结果实验期间两组小鼠PP数目均无明显变化;实验组免疫后PP淋巴细胞数量明显增生,第2周达高峰,第1、2、3周显著高于对照组(P〈0.05),其中以CD4^+T细胞增生为主,第1周~第8周高于对照组(P〈0.01),CD8^+T细胞第1周~第4周显著增高(P〈0.01),CD4^+/CD8^+比值无显著变化(P〉0.05)。结论弓形虫复合粘膜疫苗滴鼻免疫BALB/c小鼠可有效诱导肠PP部位持续性的免疫应答,从而激活肠粘膜效应部位淋巴细胞的抗弓形虫感染作用。 Objective To study the mucosal immune responses of Peyer's patches (PP) after intranasal immunization with mucosal vaccine for Toxoplasma gondii, and to observe the duration of the responses. Methods BALB/c mice were randomly divided into two groups: immunized group and control group, 48 mice per group. Mice were intranasally immunized with 20μ1 mucosal complex vaccine (20 μg STAg+1 μg CT) per mouse twice at an internal of two weeks, while control mice were given PBS solution instead. Six mice of each group were killed respectively on week 1, 2, 3, 4, 6, 8,10 and 12 after the last immunization, respectively. PP was separated and lymphocytes were isolated and counted. Percentage of CD4^+ and CD8^+ T cells was determined by immunocytochemistry. Results The number of PP in two groups had no significant changes. Lymphocytes in PP significantly increased after immunity. Lymphocytes in PP of immunized mice were higher than that of control on week 1, 3 (P〈0.05), 2 (P〈0. 0001), getting its maximum number on week 2. The CD4^+ T cell subset was increasing on week 1, 2, 3, 4, 6, 8 (P〈0.01), while CD8^+ T cells increased on week 1, 2, 3, 4 (P〈0.01). And the ratio of CD4^+ and CD8^+ Thad no changes. Conclusion Intranasal immunization with mucosal vaccine for T. gondii can effectively induce immune responses of PP to protect mice against T. gondii.
出处 《中国病原生物学杂志》 CSCD 2008年第1期27-30,共4页 Journal of Pathogen Biology
基金 国家自然科学基金项目(No.30640057) 山西省自然科学基金项目(No.20041105) 山西省高校科技研究开发重点项目(No.20041238) 山西医科大学基础医学院“学科研究方向建设基金”项目(No.20040708)
关键词 弓形虫 粘膜疫苗 滴鼻免疫 可溶性速殖子抗原 霍乱毒素 Peyer’s PATCHES Toxoplasma gondii mucosal vaccine intranasal immunization soluble tachyzoite antigen cholera toxin Peyer' s patches
  • 相关文献

参考文献25

  • 1Kasper L,Courret N,Darche S,et al.Toxoplasma gondii and mucosal immunity[J].Int J Parasitol,2004,34:401-409.
  • 2Buxton D,Innes EA.A commercial vaccine for ovine toxoplasmosis[J].Parasitology,1995,110(Suppl):S11-16.
  • 3刘龙丁,曹逸云.疫苗设计的技术基础[M]//董德祥,主编.疫苗技术基础与应用.北京:化学工业出版社,2002:44-73.
  • 4Bout DT,Mevelec MN,Velge-Roussel F,et al.Prospects for a human Toxoplasma vaccine[J].Curr Drug Targets Immune Endocr Metabol Disord,2002,2(3):227-234.
  • 5Mishima M,Xuan X,Shioda A,et al.Modified protection against Toxoplasma gondii lethal infection cyst formation by vaccination with SAG2 and SRS1[J].Vet Med Sci,2001,63(4):433-438.
  • 6Vercammen M,Scorza T,Huygen K,et al.DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1,GRA7,and ROP2 induces partially protective immunity against lethal challenge in mice[J].Infect Immun,2000,68(1):38-45.
  • 7Beghetto E,Nielsen HV,Del Porto P,et al.A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts[J].J Infect Dis,2005,191(4):637-645.
  • 8孟晓丽,殷国荣,刘红丽,石蓉,张宇斌,马秀瑞.不同剂量STAg滴鼻免疫小鼠诱导的抗弓形虫感染作用[J].中国人兽共患病学报,2006,22(3):202-205. 被引量:31
  • 9刘成芳,殷国荣,刘红丽,杨亚波,刘娟娟,管志玉.弓形虫可溶性抗原联合γ干扰素鼻内免疫小鼠的抗弓形虫感染作用[J].中国血吸虫病防治杂志,2005,17(4):293-297. 被引量:16
  • 10Elsaid MMA,Vitor RWA,Frézard FJG,et al.Protection against toxoplasmosis in mice immunized with different antigens of Toxoplasma gondii incorporated into liposomes[J].Mem Inst Oswaldo Cruz,1999,94:485-490.

二级参考文献65

共引文献109

同被引文献42

  • 1唐丽杰,欧笛,葛俊伟,徐义刚,李一经,史达,夏春丽,郁茵.表达猪传染性胃肠炎病毒S基因的重组乳酸乳球菌的构建及免疫原性分析[J].微生物学报,2007,47(2):340-344. 被引量:22
  • 2Sakai K, Yamada M. Aβ immunotherapy for Alzheimer's dis ease. Brain Nerve, 2013,65,461-468.
  • 3Hardy J, selkoe DJ. The amyloid hypothesis of Alzheimer's disease:progress and problems on the road to therapeutics. Science, 2002,297 : 353-356.
  • 4Monsonego J, Imitola J, Petovic S, et al. AI3 induced meningo encephalitis is IFN-γ dependent and is associated with T cell dependent clearance of Aβ in a mouse model of Alzheimer's disease. PNAS,2006,103 : 5048-5053.
  • 5Orgogozo JM, GiIman S, Dartigues JF, et al. Subacute menin- goencephalitis in a subset of patients with AD after Aβ 42 im munization. Neurology, 2003,61 : 46-54.
  • 6Antonella D, Manuela C, Pugliese O, et al. Cholera toxin B suhunit promotes the induction of regulatory T cells by pre venting human dendritic cell maturation. Journal of Leukocyte Biology, 2008,84 : 661 -668.
  • 7Zhang JM,Wu XB,Chuan Q,et al. A novel recombinant ade no-associated virus vaccine reduces behavioral impairment and amyloid plaques in a mouse model of Alzheimer's disease. Neurobiology of Disease, 2003,14 :365-379.
  • 8Coccia EM, Boirivant M, Boirivant M, et al. Cholera toxin subunit B inhibits IL-12 and lFN production and signaling in experimental colitis and Crohn's disease. Gut, 2005,54:1558- 1564.
  • 9Nobuyubki M, Brian C, Jacquelyn K, et al. H umoral immune response by prime boost heterologous route immunization with CTB-MPR649 684, a mucosat subunit HIV/AIDS vac- cine candidate. Vaccine, 2006,24 : 5047 -5055.
  • 10Tomiyama T. Involvement of beta amyloid in the etiology of Alzheimer's disease. Brain Nerve, 2010,62 : 691- 699.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部